Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor
There are limited reports on the use of tolvaptan for syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children. Managing serum sodium levels in SIADH patients during chemotherapy is often difficult because of the need for massive fluid infusions. We report the course of the use o...
Main Authors: | Shota Hiroshima, Hiromi Nyuzuki, Sunao Sasaki, Yohei Ogawa, Keisuke Nagasaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/8/4/293 |
Similar Items
-
Long-Term Vaptan Treatment of Idiopathic SIADH in an Octogenarian
by: Stefan Büttner, et al.
Published: (2017-03-01) -
Hyponatremia: An Unusual Presentation in a Neonate With Chromosome 1q21.1 Deletion Syndrome
by: Bakri Alzarka, et al.
Published: (2018-10-01) -
Treatment of Hyponatremia with Tolvaptan in a Patient after Neurosurgical Treatment of a Pituitary Tumor: Case Report and Review of Literature
by: Shinya Ichimura, et al.
Published: (2015-10-01) -
Tolvaptan
by: Bharath Rangarajan, et al.
Published: (2014-01-01) -
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
by: Shuzhen Wang, et al.
Published: (2018-09-01)